Corrigendum to “Effect of chiglitazar and sitagliptin on glucose variations, insulin resistance and inflammatory-related biomarkers in untreated patients with type 2 diabetes” [Diabetes Res. Clin. Pract. 183 (2022) 109171]
Titel:
Corrigendum to “Effect of chiglitazar and sitagliptin on glucose variations, insulin resistance and inflammatory-related biomarkers in untreated patients with type 2 diabetes” [Diabetes Res. Clin. Pract. 183 (2022) 109171]
Auteur:
Wang, Yuming Li, Huiqin Gao, Hui Xu, Xiaohua Cai, Tingting Wang, Huiying Zhou, Yunting Huang, Rong Su, Xiaofei Ma, Jianhua